Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
769,399
-
Shares change
-
-84,673
-
Total reported value, excl. options
-
$59,210,150
-
Value change
-
-$6,214,856
-
Put/Call ratio
-
382%
-
Number of buys
-
25
-
Number of sells
-
-18
-
Price
-
$76.95
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2021
70 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q4 2021.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 769,399 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (147,336 shares), Clough Capital Partners L P (69,800 shares), Twelve Points Wealth Management LLC (61,827 shares), Orion Portfolio Solutions, LLC (55,434 shares), ALTFEST L J & CO INC (51,782 shares), MORGAN STANLEY (41,169 shares), BANK OF AMERICA CORP /DE/ (40,682 shares), CITADEL ADVISORS LLC (35,515 shares), ROYAL BANK OF CANADA (29,287 shares), and IMC-Chicago, LLC (24,427 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.